Spire Wealth Management’s ProShares Ultra Health Care RXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-50
Closed -$2.55K 2251
2024
Q2
$2.55K Buy
+50
New +$2.48K ﹤0.01% 1966
2022
Q3
Sell
-60
Closed -$3K 2533
2022
Q2
$3K Buy
+60
New +$2.76K ﹤0.01% 2292
2022
Q1
Sell
-1,228
Closed -$69K 2821
2021
Q4
$69K Hold
1,228
﹤0.01% 1573
2021
Q3
$58K Hold
1,228
﹤0.01% 1408
2021
Q2
$57K Hold
1,228
﹤0.01% 1428
2021
Q1
$49K Buy
+1,228
New +$48.5K ﹤0.01% 1735

Other funds holding RXL

Spire Wealth Management's RXL Position: Q3 2024 in Review

Spire Wealth Management sold out of ProShares Ultra Health Care (RXL) in Q3 2024, closing a stake of 50 shares — an estimated $2.55K sold.

Spire Wealth Management first reported a position in RXL in Q1 2021 and held it in 6 quarters. The position peaked at $69K in Q4 2021. 20 funds tracked by Wall St. Rank hold RXL as of Q3 2024.

  • Spire Wealth Management reported no remaining ProShares Ultra Health Care position as of Q3 2024 after selling out during the quarter.
  • Spire Wealth Management sold 50 ProShares Ultra Health Care shares in Q3 2024, an estimated $2.55K.
  • Spire Wealth Management first reported a position in ProShares Ultra Health Care in Q1 2021 and held it in 6 quarters.
  • Spire Wealth Management's ProShares Ultra Health Care position peaked at $69K in Q4 2021.
  • 20 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q3 2024.

Based on Spire Wealth Management's 13F filing for Q3 2024, filed 15 Oct 2024.